4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.17 -0.45 (-3.57%)
As of: Oct 22, 2026 · 3:22 PM EDT

4D Molecular Therapeutics (FDMT) Total Debt (2026)

Updated

4D Molecular Therapeutics' Total Debt was $19.59 million in Q2 2026.

Analysis

4D Molecular Therapeutics (FDMT) Total Debt (2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Eli Lilly 1,170.23 Bn 1,138.82 Bn 19.71 Bn 54.91 Bn
2 Johnson & Johnson 648.85 Bn 568.71 Bn 17.30 Bn 44.65 Bn
3 AbbVie 504.91 Bn 478.02 Bn 12.70 Bn 70.82 Bn
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn 53.91 Bn
5 Novartis Ag 303.41 Bn 267.40 Bn 11.24 Bn 9.59 Bn
6 Astrazeneca 268.65 Bn 242.33 Bn 12.86 Bn 32.35 Bn
7 Amgen 242.96 Bn 198.36 Bn 7.24 Bn 57.30 Bn
8 Gilead Sciences 195.01 Bn 169.21 Bn 6.22 Bn 26.25 Bn
9 Pfizer 173.22 Bn 119.87 Bn 10.94 Bn 63.19 Bn
10 4D Molecular Therapeutics 855.21 Mn -604.73 Mn - 19.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 19.59 Mn
API Access

4D Molecular Therapeutics Total Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-debt&ticker=FDMT&period=max&api_key=YOUR_API_KEY